KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation

Apr.08
KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation
According to a Korean media report, KT&G is developing a smokeless nicotine product that delivers nicotine through oral absorption and is preparing a pilot production line for research and development.

Key Takeaways

 

  • KT&G is developing a smokeless nicotine product absorbed through the mouth and is preparing a pilot production line.
  • The pilot equipment will be supplied by Korean battery and display equipment company PNT.
  • This is the first confirmed case of KT&G building related production facilities in South Korea.
  • KT&G said the business is still in the early development stage, and launch plans for nicotine pouches and other products have not been finalized.
  • The report said nicotine pouches do not currently have formal sales authorization in South Korea, and consumers mainly buy them through overseas direct purchases or unofficial channels.

 2Firsts, April 8, 2026 

 

According to a Korean media report, KT&G is moving forward with a smokeless nicotine product business that delivers nicotine through oral absorption rather than combustion, and is preparing a pilot production line for research and development.

 

KT&G is developing an oral smokeless nicotine product

 

The report said KT&G is developing a smokeless nicotine product designed for oral nicotine absorption, and that the pilot production equipment will be supplied by battery and display equipment company PNT. This is also the first confirmed case of KT&G building related production facilities in South Korea.

 

KT&G said the business remains at an early stage of development and that no final decisions have been made. The company added that it has long been preparing next-generation tobacco product categories and is reviewing a range of products beyond e-cigarettes and vapor products, including nicotine pouches, but that neither domestic nor overseas launches have been specified.

 

Nicotine pouches are described as a representative oral nicotine format

 

The report said nicotine pouches are a representative product in the oral nicotine category. They are placed between the gum and the lip, allowing nicotine to be absorbed through the oral mucosa without combustion. KT&G previously showed interest in entering the category by participating last year in the acquisition of a European nicotine pouch company.

 

According to the report, the manufacturing process for nicotine pouches differs from that of traditional cigarettes. It involves measuring and mixing nicotine, fillers, and flavorings, followed by granulation and drying, before a fixed amount is filled into small pouches. A key part of the process is designing the filler so that nicotine is released at a controlled rate when it contacts saliva.

 

PNT will supply pilot equipment, while domestic rollout still depends on Korean regulation

 

The report said this production process shares some similarities with battery manufacturing, including continuous processes such as mixing, coating, drying, and transferring, and that such production can be implemented through roll-to-roll technology. PNT is a Korean company known for its strength in roll-to-roll technology. While about 90.00% of its business is tied to battery equipment, it also provides roll-to-roll process solutions to industries such as pharmaceuticals and medical equipment.

 

The report said the cooperation with KT&G could also mark PNT’s entry into new sectors such as food, healthcare, and consumer goods, and that if KT&G moves into commercialization, the partnership could later lead to mass-production equipment orders.

 

Global nicotine pouch competition is intensifying and KT&G has already joined overseas M&A activity

 

The report said competition in the global tobacco market is intensifying around nicotine pouches. Philip Morris International owns the Zyn nicotine pouch brand, which holds a 74.00% share of the U.S. market. British American Tobacco is targeting Europe and the United States with its Velo brand.

 

The report also said this shift is already being reflected in performance. Philip Morris’ smoke-free business now accounts for more than 40.00% of total revenue. Nicotine pouch shipment volume reached 196.00 million cans in the fourth quarter of 2025, up 19.00% year on year, while cigarette sales fell 1.50% over the same period.

 

KT&G is also preparing to enter the market. The report said the company last year participated with U.S. tobacco company Altria in the acquisition of Swedish and Norwegian nicotine pouch companies ASF AB and ASF AS. The acquisition amount was about SEK 1.76 billion (approximately USD 40.50 million, based on 1 SEK ≈ 0.023 USD), in a deal valued at about KRW 270.00 billion.

 

Domestic sales in South Korea still depend on regulatory changes

 

The report said KT&G’s oral nicotine business is aligned with the broader global market expansion trend, but that in South Korea the speed of progress will depend on whether the legal and regulatory framework is revised. Under Korea’s Tobacco Business Act, nicotine pouches may only be sold by authorized businesses. The report said there is currently no formal sales authorization, and consumers are purchasing these products mainly through overseas direct purchases or unofficial channels.

 

Image source: thelec

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
A U.S. federal court upheld Pennsylvania's vape directory law on October 14, rejecting a challenge brought by Nova Distro, 101 Distributors and companies operating Tobacco Hut retail stores. Court records show that vaping accounts for about 60% of Tobacco Hut's profits and that the chain held approximately $2 million in inventory potentially subject to seizure under the law as of June 2. Pennsylvania began enforcement on October 19. The ruling follows similar appellate decisions in other states, even as new research shows that unlisted vaping products continue to account for substantial sales in states with established directories.
Regulations
Oct.22
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia's digital labeling regime for reusable e-cigarettes and similar personal vaping devices entered its first mandatory phase in September 2026. From September 1, manufacturers, importers and other market participants must register with the national Chestny ZNAK tracking system. From December 1, newly manufactured and imported covered devices will be required to carry digital identification codes and be reported as entering circulation. Russia has also issued new operational guidance for imports, marking the transition from a voluntary pilot to phased mandatory implementation.
Sep.15
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
The vaping rate among women aged 25 to 34 in Great Britain reached 18.3% in 2025, up from 13.7% in 2024 and 8.3% in 2020, according to data from the Office for National Statistics (ONS). The figure was the highest for this group since records began in 2014 and exceeded the 14.4% recorded among men of the same age. Adults aged 25 to 34 also overtook those aged 16 to 24 as the age group with the highest vaping prevalence. Overall, about 5.4 million adults in Great Britain used e-cigarettes in 2025, broadly unchanged from the previous year.
DATA
Oct.13
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05